Some pharmacokinetic parameters of the trypanocidal drug homidium bromide in Friesian and Boran steers using an enzyme-linked immunosorbent assay (ELISA)

Pharmacokinetic studies on the trypanocidal drug homidium bromide using a competitive enzyme immunoassay (detection limit 0.1 ng/mL) are reported for non-infected Friesian and Boran steers following treatment with homidium bromide at a dose of 1.0 mg/kg b.w. Following intravenous (i.v.) treatment of Friesian steers (n = 5), the mean serum drug concentrations were 31.9 ± 2.1 and 3.9 ± 0.4 ng/ml at 1 and 24 h, respectively. The decline in serum drug concentration was tri-exponential with half-lives of 0.064 ± 0.037 h for t( 1/2 ?), 7.17 ± 1.87 h for T( 1/2 ?) and 106.3 ± 6.6 h for t( 1/2 ?) for distribution and elimination phases 1 and 2, respectively. Drug was detectable in serum for 17 days following treatment. The mean residence time (MRT) was 63.4 ± 7.5 h. Following intramuscular (i.m.) treatment of Friesian steers (n = 5), the drug concentration at 1 h after treatment was 72.5 ± 2.2 ng/mL. This declined to 9.8 ± 1.8 ng/mL at 24 h. Low concentrations of between 0.1 and 0.3 ng/mL remained in circulation for up to 90 days post-treatment. Following intramuscular treatment of Boran steers (n = 5), the mean serum drug concentration at 1 h after treatment was 112.1 ± 40.3 ng/mL. By 24 h after treatment, the concentration had fallen to 13.0 ± 3.3 ng/mL. Thereafter, the serum drug concentration-versus-time profile and the pharmacokinetic parameters obtained following non-compartmental analysis were similar to those obtained following intramuscular treatment of Friesian steers.

Saved in:
Bibliographic Details
Main Authors: Murilla, G., Holmes, P.H., Peregrine, A.S., Eisler, M.C., Ndung'u, J.M.
Format: Journal Article biblioteca
Published: Wiley 1999-10
Subjects:vaccination, cattle,
Online Access:https://hdl.handle.net/10568/35309
https://doi.org/10.1046/j.1365-2885.1999.00215.x
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-cgspace-10568-35309
record_format koha
spelling dig-cgspace-10568-353092023-12-27T19:40:58Z Some pharmacokinetic parameters of the trypanocidal drug homidium bromide in Friesian and Boran steers using an enzyme-linked immunosorbent assay (ELISA) Murilla, G. Holmes, P.H. Peregrine, A.S. Eisler, M.C. Ndung'u, J.M. vaccination cattle Pharmacokinetic studies on the trypanocidal drug homidium bromide using a competitive enzyme immunoassay (detection limit 0.1 ng/mL) are reported for non-infected Friesian and Boran steers following treatment with homidium bromide at a dose of 1.0 mg/kg b.w. Following intravenous (i.v.) treatment of Friesian steers (n = 5), the mean serum drug concentrations were 31.9 ± 2.1 and 3.9 ± 0.4 ng/ml at 1 and 24 h, respectively. The decline in serum drug concentration was tri-exponential with half-lives of 0.064 ± 0.037 h for t( 1/2 ?), 7.17 ± 1.87 h for T( 1/2 ?) and 106.3 ± 6.6 h for t( 1/2 ?) for distribution and elimination phases 1 and 2, respectively. Drug was detectable in serum for 17 days following treatment. The mean residence time (MRT) was 63.4 ± 7.5 h. Following intramuscular (i.m.) treatment of Friesian steers (n = 5), the drug concentration at 1 h after treatment was 72.5 ± 2.2 ng/mL. This declined to 9.8 ± 1.8 ng/mL at 24 h. Low concentrations of between 0.1 and 0.3 ng/mL remained in circulation for up to 90 days post-treatment. Following intramuscular treatment of Boran steers (n = 5), the mean serum drug concentration at 1 h after treatment was 112.1 ± 40.3 ng/mL. By 24 h after treatment, the concentration had fallen to 13.0 ± 3.3 ng/mL. Thereafter, the serum drug concentration-versus-time profile and the pharmacokinetic parameters obtained following non-compartmental analysis were similar to those obtained following intramuscular treatment of Friesian steers. 1999-10 2014-04-14T10:55:54Z 2014-04-14T10:55:54Z Journal Article Murilla, G.A., Holmes, P.H., Peregrine, A.S., Eisler, M.C. and Ndung'u, J.M. 1999. Some pharmacokinetic parameters of the trypanocidal drug homidium bromide in Friesian and Boran steers using an enzyme-linked immunosorbent assay (ELISA). Journal of Veterinary Pharmacology and Therapeutics 22(5): 295-300. 1407783 https://hdl.handle.net/10568/35309 https://doi.org/10.1046/j.1365-2885.1999.00215.x Copyrighted; all rights reserved Limited Access p. 295-300 Wiley Journal of Veterinary Pharmacology and Therapeutics
institution CGIAR
collection DSpace
country Francia
countrycode FR
component Bibliográfico
access En linea
databasecode dig-cgspace
tag biblioteca
region Europa del Oeste
libraryname Biblioteca del CGIAR
topic vaccination
cattle
vaccination
cattle
spellingShingle vaccination
cattle
vaccination
cattle
Murilla, G.
Holmes, P.H.
Peregrine, A.S.
Eisler, M.C.
Ndung'u, J.M.
Some pharmacokinetic parameters of the trypanocidal drug homidium bromide in Friesian and Boran steers using an enzyme-linked immunosorbent assay (ELISA)
description Pharmacokinetic studies on the trypanocidal drug homidium bromide using a competitive enzyme immunoassay (detection limit 0.1 ng/mL) are reported for non-infected Friesian and Boran steers following treatment with homidium bromide at a dose of 1.0 mg/kg b.w. Following intravenous (i.v.) treatment of Friesian steers (n = 5), the mean serum drug concentrations were 31.9 ± 2.1 and 3.9 ± 0.4 ng/ml at 1 and 24 h, respectively. The decline in serum drug concentration was tri-exponential with half-lives of 0.064 ± 0.037 h for t( 1/2 ?), 7.17 ± 1.87 h for T( 1/2 ?) and 106.3 ± 6.6 h for t( 1/2 ?) for distribution and elimination phases 1 and 2, respectively. Drug was detectable in serum for 17 days following treatment. The mean residence time (MRT) was 63.4 ± 7.5 h. Following intramuscular (i.m.) treatment of Friesian steers (n = 5), the drug concentration at 1 h after treatment was 72.5 ± 2.2 ng/mL. This declined to 9.8 ± 1.8 ng/mL at 24 h. Low concentrations of between 0.1 and 0.3 ng/mL remained in circulation for up to 90 days post-treatment. Following intramuscular treatment of Boran steers (n = 5), the mean serum drug concentration at 1 h after treatment was 112.1 ± 40.3 ng/mL. By 24 h after treatment, the concentration had fallen to 13.0 ± 3.3 ng/mL. Thereafter, the serum drug concentration-versus-time profile and the pharmacokinetic parameters obtained following non-compartmental analysis were similar to those obtained following intramuscular treatment of Friesian steers.
format Journal Article
topic_facet vaccination
cattle
author Murilla, G.
Holmes, P.H.
Peregrine, A.S.
Eisler, M.C.
Ndung'u, J.M.
author_facet Murilla, G.
Holmes, P.H.
Peregrine, A.S.
Eisler, M.C.
Ndung'u, J.M.
author_sort Murilla, G.
title Some pharmacokinetic parameters of the trypanocidal drug homidium bromide in Friesian and Boran steers using an enzyme-linked immunosorbent assay (ELISA)
title_short Some pharmacokinetic parameters of the trypanocidal drug homidium bromide in Friesian and Boran steers using an enzyme-linked immunosorbent assay (ELISA)
title_full Some pharmacokinetic parameters of the trypanocidal drug homidium bromide in Friesian and Boran steers using an enzyme-linked immunosorbent assay (ELISA)
title_fullStr Some pharmacokinetic parameters of the trypanocidal drug homidium bromide in Friesian and Boran steers using an enzyme-linked immunosorbent assay (ELISA)
title_full_unstemmed Some pharmacokinetic parameters of the trypanocidal drug homidium bromide in Friesian and Boran steers using an enzyme-linked immunosorbent assay (ELISA)
title_sort some pharmacokinetic parameters of the trypanocidal drug homidium bromide in friesian and boran steers using an enzyme-linked immunosorbent assay (elisa)
publisher Wiley
publishDate 1999-10
url https://hdl.handle.net/10568/35309
https://doi.org/10.1046/j.1365-2885.1999.00215.x
work_keys_str_mv AT murillag somepharmacokineticparametersofthetrypanocidaldrughomidiumbromideinfriesianandboransteersusinganenzymelinkedimmunosorbentassayelisa
AT holmesph somepharmacokineticparametersofthetrypanocidaldrughomidiumbromideinfriesianandboransteersusinganenzymelinkedimmunosorbentassayelisa
AT peregrineas somepharmacokineticparametersofthetrypanocidaldrughomidiumbromideinfriesianandboransteersusinganenzymelinkedimmunosorbentassayelisa
AT eislermc somepharmacokineticparametersofthetrypanocidaldrughomidiumbromideinfriesianandboransteersusinganenzymelinkedimmunosorbentassayelisa
AT ndungujm somepharmacokineticparametersofthetrypanocidaldrughomidiumbromideinfriesianandboransteersusinganenzymelinkedimmunosorbentassayelisa
_version_ 1787229995077206016